Eddie Glaude and Michelle Goodwin join The Weekend to discuss the 70+ legal challenges to Trump’s executive orders from his ...

An ancient trading post known for housing some of West Africa's most historically significant manuscripts could soon be ...

Their unparalleled opportunities for attaining a degree with worldwide recognition include being based in an incredibly ...

Imperial's international scholars shared their inspiring stories at a special event to celebrate their successes.More than 100 scholars from around ...

A runner-up in 2024’s AXA Startup Angel competition, this SME’s versatile retrofittable device could help cities manage river ...

Boehringer Ingelheim, IP Group, UK Respiratory Gene Therapy Consortium, and OXB launched the first-in-human clinical trial, known as LENTICLAIR 1.

SAN FRANCISCO and BERLIN, Feb. 20, 2025 (GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc., a biopharmaceutical company developing T cell receptor (TCR) engineered T cell therapies (TCR-T) to fight cancer ...

King Charles III and Ukraine’s Ambassador to the UK, Valerii Zaluzhnyi, visited the Centre for Injury Studies at Imperial ...

An Imperial spinout has raised £4.15m seed funding for software designed to ensure that safety- and business-critical AI systems perform as intended.

Some of Imperial Valley’s most accomplished leaders, innovators, and changemakers got their start at Imperial Valley College ...

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.

The Board of Supervisors met on Tuesday, Feb. 18 to discuss automatic aid for local fire protection to respond quicker to ...